Manchester, United Kingdom

Haoran Tang


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Haoran Tang: Innovator in Cancer Treatment

Introduction

Haoran Tang is a prominent inventor based in Manchester, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of five patents to his name, Tang is recognized for his work in the pharmaceutical industry.

Latest Patents

Tang's latest patents include groundbreaking inventions related to lysyl oxidase inhibitors. One of his notable inventions focuses on compounds that serve as inhibitors for the lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) family members. These compounds are particularly useful in treating conditions mediated by LOX and LOXL, such as cancer. His research emphasizes the potential of LOX inhibitors in treating cancers associated with the epidermal growth factor receptor (EGFR). Additionally, Tang has developed methylamine derivatives as lysyl oxidase inhibitors, which are also aimed at cancer therapy.

Career Highlights

Haoran Tang is affiliated with The Institute of Cancer Research, Royal Cancer Hospital. His work at this esteemed institution has allowed him to focus on innovative cancer therapies and contribute to the advancement of medical science. His dedication to research has led to the development of compounds that may significantly impact cancer treatment.

Collaborations

Some of Tang's notable coworkers include Richard Marais and Caroline Joy Springer. Their collaborative efforts in research have further enhanced the potential of the inventions developed at The Institute of Cancer Research.

Conclusion

Haoran Tang's contributions to cancer treatment through his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic options in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…